HLA-A and neoplasm: As shown in Fig. 6F, consistent with our previous findings, adoptive transferring Tcr-T1 could specifically attenuate HLA-A*2402-positive MKN-45 tumor growth dependent on Pep-4 NP administration, while having little effect on HLA-A*0201-positive MDA-MB-231 cells.